MSX2 Gene Craniosynostosis type 2 Genetic Test
Components: MSX2 Gene Craniosynostosis type 2 Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MSX2 Gene Craniosynostosis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MSX2 Gene Craniosynostosis type 2 NGS Genetic DNA Test gene MSX2
Test Details
The MSX2 gene is associated with a condition called craniosynostosis type 2, which is a rare genetic disorder characterized by the premature fusion of the skull bones. This condition can lead to abnormal skull shape, facial features, and potential neurological complications.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA to identify variations or mutations in specific genes associated with genetic disorders. In the case of craniosynostosis type 2, NGS can be used to identify mutations or variations in the MSX2 gene. NGS testing involves sequencing the entire coding region of the gene to identify any potential changes or mutations.
This can help in diagnosing individuals with craniosynostosis type 2 and can also be used for carrier testing in families with a history of the condition. By identifying the specific genetic mutation in the MSX2 gene, NGS testing can provide valuable information for genetic counseling, family planning, and potential treatment options for affected individuals.
Test Name | MSX2 Gene Craniosynostosis type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for MSX2 Gene Craniosynostosis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MSX2 Gene Craniosynostosis type 2 NGS Genetic DNA Test gene MSX2 |
Test Details |
The MSX2 gene is associated with a condition called craniosynostosis type 2, which is a rare genetic disorder characterized by the premature fusion of the skull bones. This condition can lead to abnormal skull shape, facial features, and potential neurological complications. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA to identify variations or mutations in specific genes associated with genetic disorders. In the case of craniosynostosis type 2, NGS can be used to identify mutations or variations in the MSX2 gene. NGS testing involves sequencing the entire coding region of the gene to identify any potential changes or mutations. This can help in diagnosing individuals with craniosynostosis type 2 and can also be used for carrier testing in families with a history of the condition. By identifying the specific genetic mutation in the MSX2 gene, NGS testing can provide valuable information for genetic counseling, family planning, and potential treatment options for affected individuals. |